The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective study to evaluate interstitial lung disease secondary to oxaliplatin-containing chemotherapy at an NCI-designated comprehensive cancer center.
Vaibhav Sahai
No relevant relationships to disclose
Halla Sayed Nimeiri
No relevant relationships to disclose
Maxwell Thomas Vergo
No relevant relationships to disclose